The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow

Journal of Electrocardiology

Volumn 39, Issue 2, 2006, Pages 211-218

  Topal, Ergun ^a   Ozdemir, Ramazan ^a   Barutcu, Irfan ^b   Aksoy, Yüksel ^a   Sincer, Isa ^a   Akturk, Erdal ^a   Çehreli, Sengül ^a  

^a INONU UNIVERSITY   (Turkey)

^b KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

Author keywords

ET 1; HRV; NO; Slow coronary artery flow; Trimetazidine

Indexed keywords

ANTIANGINA PECTORIS AGENT; ENDOTHELIN 1; NITRIC OXIDE; PLACEBO; TRIMETAZIDINE;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; EXERCISE; FEMALE; HEART RATE VARIABILITY; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RR INTERVAL; SYMPTOM;

BLOOD FLOW VELOCITY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY, AMBULATORY; ENDOTHELIN-1; EXERCISE TEST; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; REGIONAL BLOOD FLOW; STATISTICS, NONPARAMETRIC; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 33645410752     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2005.08.011     Document Type: Article

References (33)

1. R.E. Kleiger, J.F. Miller, and J.T. Bigger The multicenter post infarction research group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction Am J Cardiol 59 1987 256
2. J. Nolan, P.D. Batin, and R. Andrews Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART) Circulation 98 1998 1510
3. P.K. Goel, S.K. Gupta, and A. Agarwal Slow coronary flow: a distinct angiographic subgroup in syndrome X Angiology 52 2001 507
4. J.F. Beltrame, S.B. Limaye, and J.D. Horowitz The coronary slow flow phenomenon-a new coronary microvascular disorder Cardiology 97 2002 197
5. G.M. Rosano, P. Ponikowski, and S. Adamopoulos Abnormal autonomic control of the cardiovascular system in syndrome X Am J Cardiol 73 1994 1174
6. G.A. Lanza, A. Giordano, and C. Pristipino Relationship between myocardial 123I-metaiodobenzylguanidine scintigraphic uptake and heart rate variability in patients with syndrome X Ital Heart J 1 2000 221
7. H. Pekdemir, D. Cicek, and A. Camsari The relationship between plasma endothelin-1, nitric oxide levels, and heart rate variability in patients with slow coronary flow Ann Non Electrocardiol 9 2004 24
8. J.M. Detry, and P.J. Leclercq Trimetazidine European multicenter study versus propranolol in stable angina pectoris: contribution of Holter electrocardiographic ambulatory monitoring Am J Cardiol 76 1995 8
9. E.V. Shlyakhto, V.V. Almazov, and E.M. Nifontov Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris Am J Cardiovasc Drugs 2 2002 119
10. H. Bricaud, L. Brottier, and J.L. Barat Cardioprotective effects of trimetazidine in severe ischemic cardiomyopathy Cardiovasc Drugs Ther 4 1990 861
11. M. Marzilli Cardioprotective effects of trimetazidine: a review Curr Med Res Opin 19 2003 661
12. A. Tselepis, P. Doulias, and E. Lourida Trimetazidine protects low-density lipoproteins from oxidation and cultured cells exposed to H(2)O(2) from DNA damage Free Radic Biol Med 12 2001 1357
13. I. Maridonneau-Parini, and C. Harpey Effect of trimetazidine on membrane damage induced by oxygen free radicals in human red cells Br J Clin Pharmacol 20 1985 148
14. 2+ regulation by trimetazidine during cardiac cell acidosis Cardiovasc Drugs Ther 1 1988 677
15. M.S. Ulgen, O. Akdemir, and N. Toprak The effects of trimetazidine on heart rate variability and signal-averaged electrocardiography in early period of acute myocardial infarction Int J Cardiol 77 2001 255
16. N. Guler, B. Eryonucu, and A. Gunes Effects of trimetazidine on submaximal exercise test in patients with acute myocardial infarction Cardiovasc Drugs Ther 17 2003 371
17. A. Birand, G.Z. Kudabierdieva, and T.A. Batyraliev Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty Angiology 48 1997 413
18. T. El-Kady, K. El-Sabban, and M. Gabaly Effects of trimetazidine on myocardial perfusion and the contractile response of chronically dysfunctional myocardium in ischemic cardiomyopathy :a 24-month study Am J Cardiovasc Drugs 5 2005 271
19. G. Fragasso, P.M. Piatti, and L. Monti Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine J Am Coll Cardiol 39 2002 413
20. L. Campeau The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later Can J Cardiol 18 2002 371
21. C.M. Gibson, C.P. Cannon, W.L. Daley for the TIMI 4 Study Group TIMI frame count: a quantitative method of assessing coronary artery flow Circulation 93 1996 879
22. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology Heart rate variability: standards of measurement, physiological interpretation and clinical use Circulation 93 1996 1043
23. P. Di Pasquale, P. Lo Verso, and V. Bucca Effects of trimetazidine administration before thrombolysis in patients with anterior myocardial infarction: short-term and long-term results Cardiovasc Drugs The 13 1999 423
24. R. Ozdemir, C. Tuncer, and M. Aladag Effect of trimetazidine on late potentials after acute myocardial infarction Cardiovasc Drugs Ther 13 1999 145
25. F. Duru, M. Barton, and T.F. Luscher Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhytmic drugs? Cardiovasc Res 49 2001 272
26. W.A. Coatzee, R. Enous, and L.H. Opie Trimetazidine: effects on delayed after depolarizations (DADs) and upstroke velocity of the action potential (abstr) Cardiovac Drugs Ther 4 1990 806
27. C. Ihling, T. Szombathy, and B. Bohrmann Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis Circulation 104 2001 864
28. J.G. Meeder, P.K. Blanksma, and H.G.J.M. Crijns Mechanisms of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability Eur Heart J 16 1995 1571
29. P. Piatti, G. Fragasso, and L.D. Monti Acute intravenous l-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels Circulation 107 2003 429
30. A.T. Sezgin, A. Sigirci, and I. Barutcu Vascular endothelial function in patients with slow coronary flow Coron Artery Dis 14 2003 155
31. H. Morawietz, N. Duerrschmidt, and B. Niemann Induction of the oxLDL receptor LOX-1 by endothelin-1 in human endothelial cells Biochem Biophys Res Commun 284 2001 961
32. J.P. Faure, H. Baumert, and Z. Han Evidence for a protective role of trimetazidine during cold ischemia: targeting inflammation and nephron mass Biochem Pharmacol 66 2003 2241
33. R. Ozdemir, E. Topal, and A.T. Sezgin Findings of ambulatory blood pressure monitoring and heart rate variability in patients with Behcet's disease Am J Cardiol 92 2003 646